Some studies have shown that Niaspan treatment increased Angiopoietin-1 (Ang-1), but attenuated Angiopoietin-2 (Ang-2) expression in type 1 diabetes rats11. This evidence concerns the gene ANGPT2 and type 1 diabetes mellitus.